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Abstract 
THE EFFECTS OF REACTIVE OXYGEN SPECIES ON INTERNODAL MYELIN 
STRUCTURE, AND ROLE OF PLASMALOGEN PHOSPHOLIPIDS AS 
ENDOGENOUS ANTIOXIDANTS 
By: Adrienne Marie Luoma 
Advisor: Daniel A. Kirschner, Ph.D. 
 
Reactive oxygen species (ROS) are implicated in a range of degenerative 
conditions, including aging, neurodegenerative diseases, and neurological disorders such 
as multiple sclerosis.  Myelin is a lipid-rich multilamellar assembly that facilitates rapid 
nerve conduction in higher animals, and may be intrinsically vulnerable to oxidative 
damage given the high energetic demands and low antioxidant capacity of myelinating 
cells. To determine whether ROS can cause structural damage to internodal myelin, 
whole mouse sciatic and optic nerves were incubated ex vivo with a previously-
characterized copper (Cu)/hydrogen peroxide (HP)/o-phenanthroline (OP)-based 
hydroxyl radical-generating system followed by quantitative determination of myelin 
packing by x-ray diffraction. Exposure to Cu/OP/HP-mediated ROS caused irreversible 
myelin decompaction in both sciatic and optic nerves. The addition of the hydroxyl 
radical scavenger, sodium formate, to the ROS-producing incubation solution 
significantly prevented sciatic nerve myelin decompaction, implicating hydroxyl radical 
species in causing the damage.  Furthermore, Cu/OP/HP-mediated decompaction could 
be prevented by the addition of EDTA, which can compete with OP for Cu binding and 
sequester the metal within the bulk solution. These findings suggest that Cu/OP/HP-
dependent myelin decompaction is caused by OP-mediated membrane-targeted hydroxyl 
radical production.  Myelin membranes are particularly enriched in plasmalogen 
phospholipids, which have been linked to antioxidant activity; this enrichment may 
constitute an endogenous ROS-defense mechanism that protects ROS-vulnerable myelin 
tissue from damage.  Intriguingly, it was found that sciatic nerve myelin from 
plasmalogen deficient (Pex7 KO) mice was significantly more susceptible to ROS-
mediated decompaction than that from WT mice, supporting the role of plasmalogens as 
endogenous antioxidants. 
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Introduction 
There are certain perils associated with having an aerobic metabolism, as 1-3% of 
the oxygen we breathe is converted to the superoxide radical anion by incomplete 
mitochondrial oxygen reduction (Halliwell and Gutteridge, 2007).  The discovery of the 
enzymes superoxide dismutase and catalase, which have evolved to catalyze the 
reduction of superoxide to hydrogen peroxide and the dismutation of hydrogen peroxide 
(HP), respectively, demonstrates the potential toxicity of these reactive oxygen species 
(McCord and Fridovich, 1969).  The condition in which the production of reactive 
oxygen species (ROS) exceeds an organism’s ability to scavenge these is dubbed 
“oxidative stress” (OS), and chronic oxidative stress has been linked to many different 
degenerative conditions, as well as aging itself (Stadtman, 1992). 
Oxidative stress had been linked to pathology in a myriad of diseases, and the 
relationship between OS and the progression of neurodegenerative diseases is particularly 
strong (Halliwell, 1994).  Post-mortem analyses of Alzheimer’s disease (AD) patients 
have revealed the presence of oxidative damage to brain proteins and lipids, in addition to 
an OS-induced elevation in the cellular antioxidant systems (Huang, Moir, et al., 2004).  
The brain areas most loaded with the toxic Aβ peptide closely correlate with those 
regions containing heightened lipid peroxidation, suggesting a role of oxidative damage 
in this pathology (Lovell, Ehmann, et al., 1995).  The pathology of the demyelinating 
neuroinflammatory disease multiple sclerosis (MS) also correlates with oxidative damage.  
Examination of MS lesion sites has revealed an increase in carbonyl degradation products 
resulting from lipid acyl chain degradation in comparison from normal age-matched 
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controls (LeVine and Wetzel, 1998).  The abundance of lipid peroxidation products 
within lesion sites suggests that oxidative damage may contribute to demyelination in MS. 
Mechanisms of ROS generation have been well-studied. The superoxide radical 
anion produced as a result of intrinsic inefficiencies in aerobic metabolism is relatively 
unreactive; however, it can be converted to the acutely reactive hydroxyl radical, which is 
capable of effecting indiscriminate damage to all biomolecules (Halliwell and Gutteridge, 
2007).  It has been shown that transition metals such as copper and iron are imperative 
for the production of hydroxyl radicals, and thus induction of biological damage (Fong, 
McCay, et al., 1973; McCord and Day, 1978).  This metal-catalyzed conversion of 
superoxide radical to the hydroxyl radical has been dubbed the “metal-catalyzed Haber-
Weiss reaction”, and occurs in two steps; the first being the reduction of the metal species 
by superoxide, and second, the reaction of the reduced metal with available hydrogen 
peroxide to produce a hydroxyl radical and re-oxidized metal, also known as the Fenton 
reaction.  There is extensive literature implicating the hydroxyl radical as the ultimate 
cause of biological oxidative damage (Chevion, 1988; Shinar, Navok, and Chevion, 
1983), especially by its ability to initiate lipid peroxidation (Fridovich and Porter, 1981) 
and cause irreversible protein modifications (Stadtman, 1990). 
 The extremely high reactivity of hydroxyl radicals means that they will attack 
target molecules within a few molecular encounters of their site of generation (Chevion, 
1988). As transition metals are required for hydroxyl radical production, metal 
localization is inextricably linked to the site of their generation.  Proteins may either 
contain a chelated transition metal prosthetic group, or have an inherent affinity for 
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redox-active metals such as iron and copper (Gutteridge and Halliwell, 1982). Thus, these 
binding sites become the sites at which hydroxyl radical-mediated damage is largely 
incurred.  Binding of the metal to the biological target is necessary for the induction of 
damage, and removal of the metal from the biomolecule is sufficient for preventing this 
damage (Samuni, Aronovitch, et al., 1983; Shinar, Navok, and Chevion, 1983).  
Therefore, biological oxidative damage by hydroxyl radicals occurs in a site-specific 
fashion (Gutteridge and Wilkins, 1983). 
 In this study the effects of ROS and oxidative damage on myelin compaction 
were investigated.  Myelin is a lipid-rich sheath that insulates axons of the peripheral 
nervous system (PNS) and the central nervous system (CNS), allowing for faster action 
potential propagation via saltatory conduction.  Intersheet adhesion, and therefore 
compact structure, is predominantly mediated by Protein zero (P0) in the PNS and 
Proteolipid protein (PLP) in the CNS.  In the PNS, homophilic interactions between P0 
tetramers from opposing membranes are essential for both adequate myelination levels 
and the functionally critical step of myelin compaction (Shapiro, Doyle, et al., 1996).   
Thus, an intact P0 adhesive dimeric interface is integral to the development and function 
of PNS myelin.   
The tight compaction of adjacent membranes of the myelin sheath is essential for 
its function, and disruption of this compaction by oxidative attack could compromise its 
electrical insulation properties (Bartzokis, 2004).  The high lipid-to-protein ratio of 
myelin renders the tissue inherently vulnerable to oxidative damage (Smith, Kapoor, and 
Felts, 1999), as membrane lipids are able to sustain the propagative free radical chain 
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reaction known as lipid peroxidation, whereby initial formation of a lipid peroxyl radical 
can abstract a hydrogen atom from an adjacent unsaturated fatty acid chain, forming a 
new lipid radical species that perpetuates the cycle (Gutteridge, 1995).  It has been 
suggested that nerves in the PNS may be more sensitive to OS-induced demyelination 
than in the CNS given that markers of lipid peroxidation were elevated in PNS myelin 
only following oral administration of a copper accumulation-promoting compound to rats 
(Tonkin, Valentine, et al., 2004) despite the much larger body of work devoted to the 
effects of OS in the CNS.  Additionally, levels of the important antioxidant, glutathione, 
are lower in the PNS than in the CNS (Romero, 1996).  The studies herein will 
supplement what is known about the effects of OS on PNS myelin.   
 Myelin is unusually rich in the class of ether-linked phospholipids known as 
plasmalogens, with up to 70% of ethanlomine glyercophospholipids existing as the 
plasmalogen form (Farooqui and Horrocks, 2001).  Such an enrichment of plasmalogens 
has prompted investigations into their possible function. A potential role for 
plasmalogens as membrane-protecting antioxidants was first proposed twenty years ago, 
with the finding that plasmalogen-deficient mammalian cells were substantially more 
susceptible to OS-induced death than their plasmalogen-containing counterparts (Morand, 
Zoeller, and Raetz, 1988; Zoeller, Morand, and Raetz, 1988).  Subsequent studies have 
suggested that plasmalogens interrupt the free radical chain reactions of lipid 
peroxidation, with the vinyl ether moiety preferentially attacked by oxygen radical 
species over the intrachain double bonds of unsaturated fatty acids (Reiss, Beyer, and 
Engelmann, 1997).  However, reaction of the plasmalogen vinyl ether linkage with a 
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radical species, whether it be a hydroxyl radical of lipid peroxyl radical, will inherently 
generate another radical species, thus provoking one to question how plasmalogens may 
suppress the process of lipid peroxidation.  One proposed mechanism suggests that the 
vinyl ether radical species formed upon radical attack is less reactive than the allylic 
radical species formed after hydrogen abstraction adjacent to an intrachain double bond 
as occurred in standard polyunsaturated fatty chain (PUFA) chains (Sindelar, Guan, et al., 
1999). This proposed lower reactivity would thus interfere with the propagation stage of 
lipid peroxidation.  An alternative is that the position of the plasmalogen vinyl bond in 
close proximity to the polar head group region of a membrane bilayer reduces the 
likelihood that subsequent radical reactions will damage the polyunsaturated acyl chains 
located deeper within the membrane interior.  In this scenario, the vinyl ether is 
preferentially attacked by ROS generated in the aqueous phase and therefore closer to 
lipid polar head groups, saving intrachain double bonds from such damaging reactions 
(Engelmann, 2004; Morandat, Bortolato, et al., 2003; Murphy, 2001).  Though the 
biochemical mechanism by which plasmalogens preserve membrane integrity and cell 
viability against oxidative insult remains under investigation, a wide range of studies 
have implicated a role of plasmalogens as endogenous membrane antioxidants.  The 
generation of plasmalogen-deficient mouse strains (Brites, Motley, et al., 2003) has 
facilitated the investigation of potential plasmalogen antioxidant capacity in myelin.  
Demonstration of a protective effect would provide an explanation for the particular 
enrichment of plasmalogen lipids in myelin. 
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 Given that myelin compaction is imperative for function, it will be crucial to 
examine ROS-mediated structural changes. X-ray diffraction is a valuable tool for the 
high-resolution determination of internodal myelin membrane structure in intact, unfixed 
nerves (Caspar and Kirschner, 1971).  The use of x-ray diffraction to characterize 
membrane structure affords rapid quantitative results and avoids the lengthy tissue 
processing time and potential artifacts associated with EM.  Data obtained from myelin 
diffraction can be used to calculate the repeat period of myelin arrays, protein and lipid 
localization within arrays, and the relative amount of myelin in whole nerves.  Here it 
will be used to examine the ex vivo effects of ROS on myelin compaction. 
Earlier work has shown that isolated CNS myelin undergoes decompaction upon 
exposure to a copper and hydrogen peroxide ROS-generating system (Bongarzone, 
Pasquini, and Soto, 1995).  However, it is possible that isolated myelin obtained from 
homogenized nerves may be differentially susceptible to ROS than myelin on intact 
nerves. More recently, a link between dithiocarbamate-mediated copper accumulation, 
lipid peroxidation, and myelin structural lesions has been demonstrated in vivo in rat 
peripheral nerve (Viquez, Valentine, et al., 2008).  However, the mechanism by which 
copper contributes to myelin structural abnormalities was not provided, which we 
investigate in the current study. 
In order to examine whether plasmalogen phospholipids protect myelin sheaths 
from oxidative damage, a ROS-generating system that reproducibly induced changes to 
ex vivo myelin compaction was first developed.  The ability of the copper-hydrogen 
peroxide system to generate hydroxyl radicals is well-characterized (Chevion, 1988) and 
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biologically relevant and was thus utilized here. As hydroxyl radicals are generated at 
sites of copper itself, we also added the lipophilic copper chelator, o-phenanthroline (OP), 
which enables the transport of copper through membranes (Goldstein and Czapski, 1986).  
As myelin is particularly enriched in lipid components compared with other membranes, 
the addition of a lipophilic chelator was imperative for the induction of irreversible 
structural changes associated with oxidative damage. In the current work, we show that 
copper must be localized on or within myelin membrane bilayers in order to cause 
irreversible myelin decompaction in both optic and sciatic nerves, and that a hydroxyl 
radical-dependent mechanism is likely.  Most intriguingly, we found that sciatic nerve 
myelin from plasmalogen-deficient mice was significantly more susceptible to ROS-
mediated decompaction than that from WT mice, implicating plasmalogen phospholipids 
as endogenous antioxidants that play a role in preserving myelin structure in the presence 
of oxidative stress. 
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Materials and Methods 
Mice 
 Mice used were kindly provided by Dr. Tom Seyfried (Boston College Biology 
Department, DDY WT inbred strain) or by Dr. Pedro Brites for use in collaborative 
efforts (Pex7 KO and WT littermates as described (Brites, Motley, et al, 2003)).   
Animals were housed in the Boston College Animal Facility and cared for according to 
IACUP protocol guidelines. Animals were sacrificed by cervical dissociation before 
dissection of sciatic nerves.   
Nerve incubation/ ROS-generating system 
 Sciatic nerves were dissected from freshly sacrificed animals, and the tissue was 
continuously rinsed with phosphate-buffered saline (PBS, 154 mM NaCl, 5 mM sodium 
phosphate pH 7.4) to ensure nerve structural integrity.  Sciatic nerves were cut along their 
length to generate three different segments per nerve and thus allow conduction of three 
separate incubation experiments.  Nerves were tied at the ends with silk suture thread 
(Harvard Apparatus, Holliston, MA) to facilitate the subsequent incubation and x-ray 
diffraction process.  Nerve segments were gently stretched by securing attached suture 
threads to the ends of a plastic pipet tip before incubation in 20 mL PBS (154 mM NaCl 
and 20 mM sodium phosphate buffer pH 8.0; NaCl, sodium phosphate monobasic and 
dibasic from Sigma-Aldrich Inc.) with the indicated ROS-generating system components 
(CuSO4, o-phenanthroline, hydrogen peroxide 35 wt. % in H2O, formic acid, 
ethylenediaminetetraacetic acid disodium salt dehydrate 98%, all obtained from Sigma-
Aldrich Inc.) for 72 hours (sciatic nerves) or 24 hours (optic nerves) at RT with gentle 
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rotary shaking (< 80 rpm).  Following incubation, nerves were removed from the solution 
and loaded into 0.7 mm quartz capillaries (Charles Supper Co., Natick, MA) filled with 
the same solution.  Ends were sealed with wax to prevent fluid evaporation and to allow 
gentle stretching of nerve, ensuring parallel nerve fiber alignment during diffraction.   
 For fixation, PBS or Cu/OP/HP-treated nerves were incubated in 2% 
glutaraldehyde (8% solution in water, Sigma-Aldrich Inc.) and 0.12 M sodium phosphate 
pH 7.4 (Sigma-Aldrich Inc.) for 5 days before XRD and/or  further processing for EM. 
X-ray diffraction and myelin structure analysis 
 Diffraction experiments were carried out using CuKα fine-line radiation from a 
Rigaku x-ray generator (Rigaku/MSC Inc., the Woodlands TX 77381-5209) operated at 
40 kV by 14 mA, and diffraction patterns were recorded with a linear, position-sensitive 
detector (Molecular Metrology Inc, Northampton, MA 01060). Calibration by the 
determination of specimen-to-film distance (SFD; nomenclature reflects historical use of 
X-ray film rather than detector) was established by patterns from a sodium behanate 
powder standard, which has a fundamental spacing of d001 = 58.38Å.  Patterns were fit 
with Gaussian curves to allow precise determination of the centers of the diffraction 
peaks, and the SFD was derived using Bragg’s law (nλ = 2dsinθ; n = Bragg order, λ = 
1.542 Å, d = n * 58.38 Å, 2θ = angle from center of beam to nth Bragg order peak) and 
by solving for SFD in tan 2θ = channel coordinate of nth Bragg peak/SFD.   The SFD 
was expressed in the units of channel number, and ranged from 7997 to 8011 throughout 
all experiments discussed herein. 
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 Measurements of myelin structure conducted by aligning the nerve perpendicular 
to incident beam, which was 200 μm x 3 mm in size at the sample location, and thus with 
nerve fibers and beam in the same plane.  Diffraction patterns were obtained following a 
30 minute exposure time and analyzed with PeakFit software (Jandel Scientific, Inc.).  
Background x-ray scatter was defined as that below a line drawn connecting the local 
intensity minima, and subtracted from the overall scatter.  Diffraction peaks were fit with 
Gaussian distributions for the determination of peak center and area.  The repeat period 
of the myelin arrays was calculated by Bragg’s law, using the channel number of all peak 
centers corresponding to the observed Bragg orders. Depending on mouse genotype, the 
sciatic nerve myelin repeat period ranged from 174 to 177 Å.  If multiple arrays were 
detected within a given pattern, repeat periods were calculated for each from the 
corresponding diffraction peaks.  The relative amount of myelin (M/(M+B)) of each 
nerve sample was calculated by dividing the sum of all peak areas (M) by the total scatter 
intensity (M+B), following subtraction of scatter due to the beam itself (+/- 50 channels 
from beam center).  The % of scatter from native myelin arrays (N/M) was calculated by 
dividing the sum of peak areas corresponding to native myelin arrays (N) by the sum of 
all myelin-derived peaks (M). “Native” myelin arrays were defined as those having a 
repeat period between 168 and 180 Å.   
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Results 
 
Sciatic nerve myelin undergoes decompaction after exposure to a membrane-targeted 
hydroxyl radical-generating system 
 
Our first aim was to develop an in vitro ROS-generating system that induces oxidative 
structural alterations to myelin. The ability of the Cu/HP system to induce oxidative 
modification to biological molecules via site-specific hydroxyl radical production is well-
characterized (Fig. 1) (Chevion, 1988). We thus incubated freshly dissected intact DDY 
sciatic nerve segments for 72 hr with Cu (100 µM), HP (20 mM), or both, before 
collecting x-ray diffraction data for 30 min.  Sciatic nerve myelin retained native 176 Å 
periodicity when incubated in 100 μM Cu or 20 mM HP alone as expected, given that 
these conditions are not reported to cause oxidative damage to biomolecules (Chan, 
Peller, and Kesner, 1982; Samuni, Aronovitch, et al., 1983).  In the presence of both Cu 
and HP, the reaction between which produces damaging hydroxyl radicals, myelin also 
retained native periodicity.  However, upon co-incubation with 100 μM of the lipophilic 
copper chelator o-phenanthroline (OP), Cu, and 20 mM HP, myelin underwent dramatic 
structural changes corresponding to decompaction of both the cytoplasmic and 
extracellular appositions resulting in >210 Å periodicity (Fig. 2A).  XRD scatter from 
myelin arrays in their native, compacted, state was significantly reduced (Fig. 2B).  
Myelin decompaction was likely caused by the ability of OP to enable transport of Cu 
through the myelin membranes (Goldstein and Czapski, 1986), thereby facilitating 
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reaction between Cu and HP within the membrane bilayers. This would cause the 
generation of membrane-targeted hydroxyl radicals, damaging myelin proteins and lipids 
that are essential for preserving membrane compaction.  Cu/HP treatment alone was 
therefore unlikely to generate radical species within the immediate proximity of myelin 
membranes. When Cu/OP/HP-treated nerves were re-incubated in PBS for nine hrs, 
membranes remained in their decompacted state, indicating the induction of irreversible 
Cu/OP/HP-mediated damage (Fig. 2A).  In contrast, membrane decompaction observed 
upon incubation in low pH conditions can be reversed by subsequent incubation in PBS 
at pH 7.4 (Avila 2007). Incubation of sciatic nerves in Cu and OP alone induced neither 
decompaction nor other structural defects (Fig. 2), demonstrating that localization of the 
metal to the membrane interior alone was not sufficient to cause decompaction. 
 In order to further examine the effects of Cu/OP/HP treatment on myelin structure, 
DDY mouse sciatic nerve segments were incubated in PBS alone or in Cu/OP/HP for 72 
h at RT.  Nerves were then fixed in 2% glutaraldehyde/0.12 M phosphate buffer, which 
was previously determined to be an optimal fixative for preserving the structural integrity 
of myelin membranes (Avila 2007).   X-ray diffraction patterns of the fixed, PBS or 
Cu/OP/HP pre-treated nerves were then obtained to determine whether the process of 
fixation itself had caused alterations in myelin structure (Fig. 3).  Fixation did cause 
moderate decompaction in PBS-alone treated nerves (d = 193 Å after fixation, compared 
with d = 177 Å before), but had very little effect on the Cu/OP/HP-treated nerves (d = 
227 Å after fixation, compared with d= 224 Å before).  These same nerves were then sent 
for electron microscopy (EM) processing examination.  It is evident from EM that 
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Cu/OP/HP-treatment causes myelin membrane decompaction and disordering (Fig. 4). 
Thus, both XRD and EM demonstrate that the ROS-generating system used here causes 
gross structural alterations in myelin structure. 
 Additional experiments were then conducted to validate the direct role of reactive 
oxygen species in Cu/OP/HP-mediated myelin decompaction.  Sodium formate (formate) 
is an established hydroxyl radical scavenger that has been used extensively to implicate 
these species in effecting biological damage (Chan, Peller, and Kesner, 1982; Chevion, 
1988; Que, Downey, and So, 1980).  Addition of formate (10 and 20 mM) to Cu/OP/HP-
incubated sciatic nerves prevented decompaction in a dose-dependent manner, as can be 
seen by the presence of diffraction peaks corresponding to those of the PBS-treated 
control (Fig. 5A) and quantified in Fig. 5B. Formate-mediated prevention of Cu/OP/HP-
induced decompaction was highly significant (Figure 4, p = 0.009, Cu/OP/HP vs. 
Cu/OP/HP/20 mM form).   
As copper chelation by OP was found to be imperative for ROS-mediated myelin 
decompaction, it was reasoned that a water-soluble Cu-chelator may be able to prevent 
this decompaction. EDTA can successfully compete with OP for Cu binding (Gutteridge 
and Halliwell, 1982), thus sequestering Cu in the bulk incubation solution and away from 
the myelin membrane target (Chevion 1988). The addition of EDTA prevented 
Cu/OP/HP-induced decompaction, with the percentage of x-ray scatter from native 
myelin arrays statistically indistinguishable from that of the PBS control (Fig. 6).  
Taken together, these results provide evidence for a Cu/OP/HP-mediated 
production of hydroxyl radicals within, and damage to, the myelin membranes, leading to 
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an irreversible decompaction. Sequestration of Cu by EDTA, presumably within the bulk 
solution away from the membrane targets, was sufficient to prevent Cu/OP/HP-mediated 
damage. 
 
Plasmalogen phospholipids offer sciatic nerve myelin protection from ROS-mediated 
decompaction 
 
Plasmalogen phospholipids have been implicated as endogenous protectors 
against oxidative insults (Morand, Zoeller, and Raetz, 1988; Zoeller, Morand, and Raetz, 
1988), and are particularly enriched in myelin membranes (Farooqui and Horrocks, 2001), 
suggesting a role in potential protection from the highly oxidative environment in 
neuronal tissue. Pex7 KO mice have dramatically reduced levels of plasmalogen 
phospholipids in all tissues due to impaired peroxisomal import of an essential 
plasmalogen biosynthesis enzyme (Brites, Motley, et al, 2003), and thus in comparison 
with WT littermates, can be used to examine whether plasmalogens may have a 
protective role against oxidative insult to myelin membranes. 
In order to determine whether there exist any myelin structural abnormalities or 
packing instability associated with plasmalogen deficiency that could confound studies of 
ROS susceptibility, sciatic nerves from Pex7 KO and WT littermates were dissected and 
incubated for 72 hr at RT in PBS before examination with XRD.  Myelin periodicity was 
not significantly different from WT (p = 0.22), indicating that plasmalogen deficiency 
does not compromise myelin packing stability (Fig. 7). The relative amount of myelin of 
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Pex7 KO nerves was slightly lower than of WT nerves (Fig. 7, p = 0.045), as was the % 
of this myelin found in native, compacted arrays (Fig. 9, PBS).  However, these 
differences were small, and more importantly the myelin repeat period was not 
statistically different, thus allowing the examination of ROS-mediated effects on 
compaction without prohibitory confounding variables. These findings indicate that 
sciatic nerve myelin from Pex7 KO animals possesses similar structural stability as that 
from WT animals. 
 We then examined Cu/OP/HP dose-dependent decompaction of WT sciatic nerve 
myelin; this was conducted to find intermediate concentrations of ROS-generating 
components that may differentially affect WT and Pex7 KO myelin.  After 72 hrs 
incubation in 5 mM HP in the presence of Cu/OP (100µM/100 µM), WT sciatic nerve 
myelin largely maintained its native, 174 Å-compacted state as evidenced by the 
percentage of total x-ray scatter emanating from compact myelin arrays (Fig. 8,9 WT) 
After incubation in Cu/OP/10 mM HP, WT sciatic nerve myelin still largely retained its 
native compaction; only the highest dose of 20 mM HP induced near total decompaction 
(Fig. 8,9 WT). 
 Having shown that WT sciatic nerve myelin undergoes decompaction in a 
Cu/OP/HP dose-dependent fashion, we then evaluated the susceptibility of Pex7 KO 
sciatic nerve myelin to these conditions. In contrast to WT, a substantial proportion of 
Pex7 KO myelin underwent decompaction after incubation in Cu/OP/5 mM HP, with the 
XRD scatter from native compact myelin comprising less than 50% of total myelin 
scatter in 3 separate experiments (Fig. 8A, Fig. 9). At the higher 10 mM HP dose, scatter 
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from native, compacted myelin was almost undetectable; nearly all membrane arrays 
were found to have decompacted to >210Å periodicity  (Fig. 8B, Fig. 9).  In contrast, 
80% of sciatic nerve myelin from WT animals remained in its native compacted state 
after identical Cu/OP/10 mM HP treatment (Fig. 8B, Fig. 9).  These findings were highly 
statistically significant with p < 0.0001.  Thus, these results indicate that plasmalogen-
deficient myelin has a heightened sensitivity to ROS-mediated decompaction. 
It was found that the radical scavenger sodium formate was able to partially 
protect WT sciatic nerve myelin from Cu/OP/HP-induced decompaction, implicating the 
central role of hydroxyl radicals in this effect.  Therefore, formate should similarly be 
capable of protecting Pex7 KO myelin from the effects of the Cu/OP/HP ROS-generating 
system; this protection would demonstrate that a ROS-scavenging defect in Pex7 KO 
myelin is resulting in the heightened sensitivity to Cu/OP/HP. The lowest concentration 
of HP that in the presence of Cu/OP caused complete decompaction in WT and Pex7 KO 
animals was used to determine whether formate could offer protection.  It was found that 
formate was able to partially prevent Cu/OP/HP-mediated decompaction of Pex7 KO 
nerves, though 20 mM formate was not as effective at preserving native membrane 
structure as in WT nerves (Fig. 10, 11).  Though two different experiments were shown, 
more data would be needed to demonstrate that formate statistically prevents 
decompaction in Pex7 KO sciatic nerve myelin. 
Together, these results demonstrate that myelin from Pex7 KO sciatic nerves is 
more sensitive to ROS-induced decompaction, implicating plasmalogen phospholipids as 
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endogenous antioxidants capable of preserving native myelin compaction after exposure 
to an oxidative insult.   
 
Effects of ROS on optic nerve myelin decompaction 
 
Optic nerve myelin also underwent irreversible decompaction upon exposure to 
the Cu/OP/HP ROS-generating system, and similarly maintained predominantly native 
periodicity when incubated in either Cu or HP alone (Fig. 12).  Myelin periodicity 
increased dramatically from 157 Å  to >230 Å after 24 hours in the present of Cu/OP/HP 
Nerve incubation time was reduced to 24 hours, versus 72 hours in sciatic nerve, as 
longer incubation in Cu/OP/HP was found to compromise whole nerve structural 
integrity that prevented capillary loading of the nerve.  Optic nerves are not protected by 
connective tissue to the same extent as are sciatic nerves, and thus ROS treatment may 
more rapidly cause nerve damage.  The effects of Cu/OP/HP on optic nerve myelin 
structure were confounded by the ability of HP and Cu/OP alone to induce decompaction; 
this was in disagreement with findings from sciatic nerve studies and known 
requirements for ROS-mediated damage.  Optic nerve myelin may be intrinsically more 
sensitive to these incubation components, and the concentration of ROS-generating 
components may need adjustment such that severe structural changes are not observed in 
the absence of requisite ROS generation components.  A mechanism for the differential 
optic nerve ROS susceptibility observed here would contribute to the general 
understanding of what mediates ROS-dependent decompaction. 
17 
  Characterization of the effects of ROS on Pex7 KO optic nerve myelin 
decompaction was precluded by the number of animals available and the small size of the 
nerves, which prevented segmenting as with sciatic nerves that allowed for three 
diffraction experiments per nerve.  Furthermore, Pex7 KO optic nerves are severely 
hypomyelinated (Avila 2007), which would confound studies of ROS-susceptibility. 
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Discussion 
We have demonstrated that ex vivo exposure of sciatic and optic nerves to an 
ROS-generating system causes irreversible membrane decompaction, and that sciatic 
nerve myelin from plasmalogen-deficient mice possesses a heightened sensitivity to 
decompaction caused by the oxidative insult.  The decompaction caused by exposure to 
the Cu/OP/HP system is presumably mediated by hydroxyl radicals, as evidenced by the 
protective effect of the well-known hydroxyl radical scavenger, sodium formate.  Given 
that plasmalogen phospholipids also protected myelin membranes from ultrastructural 
damage induced by Cu/OP/HP incubation, evidence for the role of plasmalogens as ROS 
scavengers has been provided. Such a role may explain their particular enrichment in 
myelin membranes. 
We found that hydroxyl radical production must be targeted to the myelin 
membranes via the lipophilic copper chelator OP in order to cause decompaction; 
hydroxyl radicals produced in the bulk incubation solution by Cu-EDTA sequestration 
did not induce changes in myelin structure (Fig. 6).  This finding is in accord with the 
site-specific model of transition metal-catalyzed oxidative damage, whereby hydroxyl 
radicals inflict damage at the site of their formation – at the metal binding site – because 
of their extremely high reactivity (Chevion, 1988).  The site-specific mechanism of 
damage may be particularly true in the case of membranes, as hydroxyl radicals 
generated in aqueous surroundings would have little chance of initiating lipid 
peroxidation  in the membrane interior (Schaich, 1992).  Thus, the known ability of OP to 
enable transmembrane Cu transport (Goldstein, and Czapski, 1986; Samuni, Aronovitch, 
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et al., 1983) was required to induce myelin ultrastructural damage as demonstrated here.  
This is also supported by the protective effect of EDTA (Fig. 6), which can compete with 
OP for Cu binding and sequester the metal in the bulk incubation solution (Gutteridge 
and Halliwell, 1982). It is not known whether OP chelation causes Cu to localize within 
the bilayer interior or within the polar head group region.   
Formate was found to mitigate membrane damage induced by Cu/OP/HP 
exposure; however, the concentrations used here were likely not high enough to 
completely protect against oxidative decompaction.  Higher concentrations were not 
utilized as myelin can undergo decompaction simply by incubation in a high ionic 
strength solution (Inouye, and Kirschner, 1988), which would have confounded the 
detection of a greater protective effect against the ROS insult. The incomplete protection 
afforded by formate is in agreement with prior studies on ROS damage to biomolecules, 
and can be explained by the site-specific theory of transition metal-catalyzed free radical 
damage.   It has been reported that scavenger concentrations as high as 0.1 to 1 M are 
required to ensure that sufficient amounts are present at the site of radical generation and 
can therefore effectively scavenge nascent hydroxyl radicals (Goldstein and Czapski 
1986). 
The biochemical mechanism by which Cu/OP/HP treatment causes myelin 
membrane decompaction remains to be elucidated.  Homodimeric interactions of the 
major myelin adhesive protein, P0, are requisite for proper compaction (Shapiro, Doyle, 
et al., 1996), and thus it is reasonable to speculate that Cu/OP/HP may induce oxidative 
modifications to P0 that disrupt the contact interfaces given the damaging effects of ROS 
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on myelin proteins that have been demonstrated in investigations using isolated CNS 
myelin (Konat and Wiggins, 1985).   One must also consider the potential roles of lipid 
peroxidation in mediating decompaction, given that OP can transport Cu through, and 
potentially localize to, the membrane interior.  The role of lipid peroxidation in 
potentially mediating myelin decompaction becomes especially important when 
considering the observed protective effect of plasmalogen phospholipids.  
Though the chemical mechanism by which Cu/OP/HP causes myelin damage has 
not been experimentally determined, our results show that plasmalogen phospholipids are 
capable of protecting against this ultrastructural damage by comparison of WT and Pex7 
KO myelin ROS-susceptibility.  Many prior studies have investigated the ability of 
plasmalogens to mitigate PUFA peroxidation in model membrane systems (Reiss, Beyer, 
and Engelmann, 1997); however, several different mechanisms accounting for the 
antioxidant effect have been proposed.  The prevailing notion seems to be that 
plasmalogens interfere with the propagation, rather than initiation, step of lipid 
peroxidation (Morandat, Bortolato, et al., 2003; Murphy, 2001).  Thus, peroxidation of a 
PUFA by a hydroxyl radical first generates a lipid peroxyl or alkoxyl radical (initiation), 
which then reacts with plasmalogen vinyl ether, forming a new vinyl ether radical species 
(Sindelar, Guan, et al., 1999).  How would the formation of a new radical species 
constitute a protective antioxidant mechanism?  Two theories have been proposed to 
account for this apparent paradox.  First is that the radical species formed from vinyl 
ether oxidation is more chemically stable than the alkoxyl radical that would be generated 
after transition-metal catalyzed lipid hydroperoxide degradation and thus unable to 
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initiate PUFA peroxidation (Sindelar, Guan, et al., 1999).  A second possibility takes into 
account the proximity of the vinyl ether moiety to the polar head group region of 
membrane bilayers (Murphy, 2001). The 1’C carbon vinyl ether radical formed following 
ROS radical attack is sterically segregated from the bulk pool of polyunsaturated fatty 
acids in the membrane interior, and potentially is unable to propagate further radical 
reactions given the lack of susceptible C-H bonds (Murphy, 2001).  Plasmalogen-
deficient sciatic nerve myelin was significantly more susceptible to ROS-mediated 
decompaction than was WT myelin, but this susceptibility to decompaction was restored 
to near WT levels when co-incubated with sodium formate.  This raises the possibility 
that formate is serving a similar role as plasmalogen in protecting against Cu/OP/HP-
mediated decompaction.  Formate is an anionic, water-soluble compound, and may not be 
able to penetrate deep within the bilayers.  If the Cu-OP complex, which serves as the 
nucleation site for hydroxyl radical production, similarly localizes near the polar head 
group region of the bilayer, then formate would have the opportunity to scavenge the 
hydroxyl radicals formed upon Cu-OP reaction with HP (Schaich, 1992).  Similarly, the 
vinyl ether moiety of the plasmalogen lipids resides by the polar head group region and 
potentially could react with locally produced hydroxyl radicals, preventing their reaction 
with PUFAs and initiation of lipid peroxidation in the membrane interior.   
The precise mechanism of plasmalogen ROS scavenging remains to be 
determined, both in light of the current findings and in general.  Analysis of PUFA 
degradation following Cu/OP/HP treatment of WT and Pex7 KO nerves would indicate 
whether plasmalogen phospholipids can protect from this effect.  It could also be 
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examined whether plasmalogens protect myelin proteins from damage upon ROS 
exposure by Western blotting and/or mass spectroscopy of whole nerve homogenate.    
In summary, an ROS-generating system capable of causing ex vivo sciatic and 
optic nerve myelin decompaction has been developed.  The decompaction was found to 
be dependent on membrane-targeted hydroxyl radical production, as evidenced by the 
protective roles of a hydroxyl radical scavenger and the water-soluble cation chelator 
EDTA.  The enhanced susceptibility of sciatic nerve myelin from plasmalogen-deficient 
mice to decompaction upon ROS exposure suggests that these lipid species may play a 
role as endogenous antioxidants in myelin.  Plasmalogens in vivo may therefore play an 
important role in the preservation of myelin structural integrity during aging- and 
neurodegenerative disease-associated oxidative stress.  
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Figures 
Figure 1.  Mechanism of in vitro ROS production. 
A.  Cu (II) is reduced by hydrogen peroxide (HP) to produce Cu(I) and a hydroperoxyl 
radical, which rapidly deprotonates to form the largely unreactive superoxide radical.  
The reduced Cu(I) species reacts with another equivalent of HP to generate a hydroxyl 
radical, regenerating Cu(II).  This cycle will proceed until HP is quenched.  Arrows 
indicate components added during in vitro ROS production. 
B.    Schematic showing that the site of hydroxyl radical damage is dependent on the site 
of metal (copper in this case) localization.   
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Figure 1.  Mechanism of in vitro ROS production. 
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Figure 2. Incubation of sciatic nerves with an ROS-generating system induces 
irreversible myelin decompaction.  
A. Representative XRD patterns from DDY mouse sciatic nerves incubated 72 h at RT in 
Cu (100 μM), OP (100 μM), and/or HP (20 mM) as described in materials and methods. 
A Cu/OP/HP-treated nerve was additionally incubated in PBS for 24 hr before x-ray 
diffraction. Patterns are shown vertically displaced from each other for enhanced clarity. 
B. Quantification of x-ray scatter from myelin arrays in native, compacted state from 
DDY mouse sciatic nerves incubated as in A. The total scatter attributed to native myelin 
arrays was divided by the total scatter after background subtraction.  The averages are 
standard deviations were calculated from eleven (PBS), three (Cu), five (Cu/OP), one 
(HP), two (Cu/HP) and thirteen (Cu/OP/HP) separate experiments. 
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Figure 2. Incubation of sciatic nerves with an ROS-generating system induces 
irreversible myelin decompaction. 
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Figure 3. Glutaraldehyde fixation does not change myelin packing of control or 
Cu/OP/HP-treated sciatic nerves.   
A. XRD patterns from DDY mouse sciatic nerves incubated 72 h at RT in PBS and either 
analyzed immediately (PBS fresh) or fixed at RT for five days in 2% glutaraldehyde/0.12 
M sodium phosphate pH 7.4 (PBS fixed).  Nerves were mounted in 0.7 mm quartz 
capillaries filled with their respective incubation solution before obtaining diffraction 
patterns for 30 min.  Patterns are shown vertically displaced from each other for 
enhanced clarity. 
B. XRD patterns from DDY mouse sciatic nerves incubated 72 h at RT in PBS + Cu (100 
μM), OP (100 μM), and/or HP (20 mM)  and either analyzed immediately (Cu/OP/HP 
fresh) or fixed at RT for five days in 2% glutaraldehyde/0.12 M sodium phosphate pH 7.4 
(Cu/OP/HP fixed).  Nerves were mounted in 0.7 mm quartz capillaries filled with their 
respective incubation solution before obtaining diffraction patterns for 30 min. 
 
 
 
 
 
 
 
 
 
28 
Figure 3. Glutaraldehyde fixation does not change myelin packing of control or 
Cu/OP/HP-treated sciatic nerves. 
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Figure 4. Cu/OP/HP sciatic nerve treatment causes disordering and decompaction of 
myelin lamellae.  
Sciatic nerves from DDY mice were incubated with PBS or with HP/Cu/OP as described 
in Figure 1a, and then fixed for five days in 2% glutaraldehyde/0.12 M sodium phosphate 
pH 7.4.  EM images were obtained following OsO4 staining, dehydration, embedding, 
and thin sectioning.   
A. EM of sciatic nerve myelin that had been incubated for 72 h at RT in PBS before 
fixation and processing. 
B. EM of sciatic nerve myelin that had been incubated for 72 h at RT in Cu (100 μM), 
OP (100 μM), and HP (20 mM) before fixation and processing.   
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Figure 4. Cu/OP/HP sciatic nerve treatment causes disordering and decompaction of 
myelin lamellae. 
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Figure 5.  Cu/OP/HP-induced sciatic nerve myelin decompaction is mitigated by addition 
of a hydroxyl radical scavenger.  
A. Representative XRD patterns from DDY mouse sciatic nerves incubated 72 h at RT in 
PBS alone, Cu (100 μM), OP (100 μM), and  HP (20 mM), or Cu/OP/HP with sodium 
formate (10 or 20 mM).  Patterns are shown vertically displaced from each other for 
enhanced clarity. 
B.  Quantification of x-ray scatter from myelin arrays in native, compacted state after 
treatment as in A. The total scatter attributed to native myelin arrays was divided by the 
total scatter after background subtraction.  The averages are standard deviations were 
calculated from eleven (PBS), thirteen (Cu/OP/HP), two (Cu/OP/HP/10 mM form) and 
four (Cu/OP/HP/20 mM form) separate experiments. ** p = 0.009, Cu/OP/HP vs. 
Cu/OP/HP 20 mM form. 
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Figure 5.  Cu/OP/HP-induced sciatic nerve myelin decompaction is mitigated by addition 
of a hydroxyl radical scavenger. 
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Figure 6. EDTA largely prevents Cu/OP/HP-mediated sciatic nerve myelin 
decompaction. 
(a) Representative XRD patterns from DDY mouse sciatic nerves incubated 72 h at RT in 
PBS alone, Cu (100 μM), OP (100 μM), and  HP (20 mM), or Cu/OP/HP with EDTA  (1 
mM).  Patterns are shown vertically displaced from each other for enhanced clarity. 
(b) Quantification of x-ray scatter from myelin arrays in native, compacted state. The 
total scatter attributed to native myelin arrays was divided into the total scatter after 
background subtraction.  The averages are standard deviations were calculated from 
eleven (PBS), thirteen (Cu/OP/HP), and three (Cu/OP/HP/EDTA) separate experiments.  
** p = 0.0002. 
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Figure 6. EDTA largely prevents Cu/OP/HP-mediated sciatic nerve myelin 
decompaction. 
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Figure 7. Sciatic nerve myelin from plasmalogen-deficient mice has a similar structure 
and stability to that from WT mice. 
A. Representative XRD patterns from Pex7 KO and WT littermate control mouse sciatic 
nerves incubated for 72 h at RT in 20 mL of PBS (154 mM NaCl, 20 mM phosphate 
buffer pH 8.0).  Nerves were mounted in 0.7 mm quartz capillaries filled PBS before 
obtaining diffraction patterns for 30 min. Patterns are shown vertically displaced from 
each other for enhanced clarity. 
B. Scatter plot comparing the average myelin repeat period in Å and the relative amount 
of myelin of Pex7 KO and WT littermate control sciatic nerve myelin after incubating for 
72 h at RT.  Plots show the results of four experiments (WT) and three experiments (Pex7 
KO).  The average myelin repeat period does not differ between WT and Pex7 KO 
animals (p = 0.22).  Pex7 KO sciatic nerves have a slightly lower relative amount of 
myelin than do WT sciatic nerves (p = 0.045).  
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Figure 7. Sciatic nerve myelin from plasmalogen-deficient mice has a similar structure 
and stability to that from WT mice. 
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Figure 8.  Sciatic nerve myelin from Pex7 KO mice is more vulnerable to ROS-mediated 
decompaction. 
A. Representative XRD patterns from Pex7 KO or WT littermate control mouse sciatic 
nerves incubated 72 h at RT in Cu (100 μM), OP (100 μM), and HP (5 mM).   
B. Same as in A, except that HP was at 10 mM. 
C. Same as in A and B, except that HP was at 20 mM. 
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Figure 8.  Sciatic nerve myelin from Pex7 KO mice is more vulnerable to ROS-mediated 
decompaction. 
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Figure 9. Sciatic nerve myelin from Pex7 KO mice is more vulnerable to ROS-mediated 
decompaction.   
Quantification of x-ray scatter from myelin arrays in native, compacted state in Pex7 KO 
and WT littermate control mouse sciatic nerves following treatment conditions as 
indicated. The total scatter attributed to native myelin arrays was divided by the total 
scatter after background subtraction.  The averages are standard deviations were 
calculated from four (WT, PBS), six (WT, Cu/OP/5 mM HP), seven (WT, Cu/OP/10 mM 
HP), four (WT, Cu/OP/ 20 mM HP), three (Pex7 KO, PBS), three (Pex7 KO, Cu/OP/5 
mM HP), four (Pex7 KO, Cu/OP/10 mM HP) and one (Pex7 KO, Cu/OP/20 mM HP) 
separate experiments. * p = 0.013 , ** p <0.0001. 
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Figure 9. Sciatic nerve myelin from Pex7 KO mice is more vulnerable to ROS-mediated 
decompaction. 
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Figure 10. Pex7 KO sciatic nerve myelin decompaction induced by Cu/OP/HP treatment 
is mitigated by addition of a hydroxyl radical scavenger. 
A. Representative XRD patterns from WT (littermate control) sciatic nerves incubated 72 
h at RT in PBS alone, Cu (100 μM), OP (100 μM), and  HP (20 mM), or Cu/OP/HP with 
sodium formate (form, 20 mM). Two patterns are shown for the Cu/OP/HP/20 mM form 
condition as only those two experiments were conducted. Patterns are shown vertically 
displaced from each other for enhanced clarity. 
B. XRD patterns from Pex7 KO sciatic nerves incubated 72 h at RT in PBS alone, Cu 
(100 μM), OP (100 μM), and  HP (10 mM), or Cu/OP/HP with sodium formate (form, 10 
or 20 mM).  Two patterns are shown for the Cu/OP/HP/20 mM form condition as only 
those two experiments were conducted. 
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Figure 10. Pex7 KO sciatic nerve myelin decompaction induced by Cu/OP/HP treatment 
is mitigated by addition of a hydroxyl radical scavenger. 
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Figure 11. Pex7 KO sciatic nerve myelin decompaction induced by Cu/OP/HP treatment 
is mitigated by addition of a hydroxyl radical scavenger.  
Quantification of x-ray scatter from myelin arrays in native, compacted state treated as 
indicated.  The total scatter attributed to native myelin arrays was divided by the total 
scatter after background subtraction.   
A. WT (littermate control) sciatic nerves were incubated 72 h at RT in PBS alone, Cu 
(100 μM), OP (100 μM), and HP (20 mM), or Cu/OP/HP with sodium formate (form, 20 
mM). The averages are standard deviations were calculated from three (PBS and 
Cu/OP/20 mM HP) separate experiments, whereas the % scatter from native myelin was 
shown for two different experiments of the Cu/OP/HP 20 mM form condition. 
B.  Pex7 KO sciatic nerves were incubated 72 h at RT in PBS alone, Cu (100 μM), OP 
(100 μM), and HP (10 mM), or Cu/OP/HP with sodium formate (form, 10 or 20 mM).  
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Figure 11. Pex7 KO sciatic nerve myelin decompaction induced by Cu/OP/HP treatment 
is mitigated by addition of a hydroxyl radical scavenger. 
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Figure 12.  Incubation of WT optic nerves with an ROS-generating system induces 
irreversible myelin decompaction. 
A. Representative XRD patterns from DDY mouse optic nerves incubated 24 h at RT in 
Cu (100 μM), OP (100 μM), and/or HP (20 mM).  Incubations were conducted as 
described in materials and methods, and diffraction patterns were obtained over 60 min. 
A Cu/OP/HP-treated nerve was additionally incubated in PBS for 8 hr before x-ray 
diffraction. Patterns are shown vertically displaced from each other for enhanced clarity 
B. Quantification of x-ray scatter from myelin arrays in native, compacted state from 
DDY mouse optic nerves incubated as in A. The total scatter attributed to native myelin 
arrays was divided by the total scatter after background subtraction.  The averages and/or 
standard deviations were calculated from two (PBS), two (Cu), one (Cu/OP), two (HP), 
and five (Cu/OP/HP) separate experiments. 
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Figure 12.  Incubation of WT optic nerves with an ROS-generating system induces 
irreversible myelin decompaction. 
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Figure 13. Additional sciatic nerve control experiments. Representative XRD patterns 
from DDY mouse sciatic nerves incubated 72 h at RT in PBS, OP (100 μM), or formate 
(20 mM) as described in materials and methods.  Patterns are shown vertically displaced 
from each other for enhanced clarity. 
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Figure 13. Additional sciatic nerve control experiments. 
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